C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J
HoldCIN Rating 55/100How is this calculated?

Tilray's FY26 Math: EBITDA Beats, Cash Burn Still the Question

Tilray reported fiscal 2026 revenue of $915.454M and adjusted EBITDA of $61.139M, yet free cash flow stayed negative $98.624M — a capital-cycle story with cross-market read-throughs for US MSOs and ancillaries.

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this, straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.